Surgical Shipping Verified by LostJobs.AI: October 25, 2026

OTTAVA Robotic Surgical System

Made by Johnson & Johnson MedTech

OTTAVA Robotic Surgical System

Photo: Johnson & Johnson MedTech

Key specs
fda pathway
De Novo, July 2026
architecture
four robotic arms integrated into the operating table; arms deploy for surgery and stow beneath the table
footprint claim
J&J says 30-50% less OR floor space than boom- and cart-mounted systems (company comparison, as of September 2025)
planned expansion
urology and gynecology
cleared procedures
Roux-en-Y gastric bypass, gastrectomy, cholecystectomy, splenectomy, gastric sleeve, small bowel resection, appendectomy, lysis of adhesions, fundoplication, hiatal hernia repair
indications in trial
inguinal hernia (US IDE trial under way)

Who's exposed

Jobs in the threat radius

  • surgical first assistant
  • circulating nurse (operating room)
  • surgical technologist (scrub tech)

Deployment status

FDA granted De Novo authorization in July 2026. J&J's Q3 2026 call said commercialization is under way and that it has signed its first commercial customer, without naming the customer, a system count or a procedure count. The launch is deliberately limited to select US customers. Before authorization the system was used in a US clinical trial that began with a gastric bypass at Memorial Hermann-Texas Medical Center in April 2025. We found no named hospital with a commercially installed OTTAVA yet. We list it as shipping because it is cleared and being sold, but the installed base today is effectively zero to a handful of units, and J&J has not said which.

When this hits the labor market

Near term, 1-3 years, OTTAVA changes very little for operating-room staffing. It is one new platform entering a market where Intuitive's da Vinci holds the installed base, and J&J says adoption will build over time. Over 3-5 years the thing to watch is the table-integrated design: if arms that stow under the table really cut the cart-and-boom footprint, smaller ORs and ambulatory sites can take a robot, and robotic volume spreads to hospitals that do not have one. Roles with the most exposure on migrating cases are the surgical first assistant and the scrub technologist, whose manual retraction and instrument-handoff work shrinks as robotic technique spreads. Surgeons are not the exposed group here.

The third big soft-tissue platform

For two decades U.S. soft-tissue robotic surgery meant one name, Intuitive. Medtronic’s Hugo broke that in December 2025. In July 2026 the FDA granted J&J De Novo authorization for OTTAVA, and the market now has three large-cap players with a cleared product. J&J’s CEO called it the world’s first table-integrated soft-tissue robotic system, which is the company’s claim, and a fair description of the design.

What is actually different

OTTAVA mounts four robotic arms on the operating table itself. They deploy for the case and fold away underneath when it ends. J&J says that frees 30 to 50 percent of the floor space a boom- or cart-mounted system takes. That is J&J’s own comparison, dated to September 2025, and we have not seen an independent measurement. The cleared indications cover upper-abdominal and related general surgery: gastric bypass, sleeve, gastrectomy, cholecystectomy, splenectomy, small bowel resection, appendectomy, hernia repair at the hiatus and others. An inguinal hernia indication is still in a US trial, and J&J plans urology and gynecology after that.

How early this is

The honest number for installed base is unknown. J&J says it has signed its first commercial customer and will launch with select U.S. hospitals. It named none, gave no system count and no price. At the Q3 call a J&J executive said revenue would build over time. We would not read this as a deployment story yet. It is a clearance story.

Why we care for LostJobs

Surgical robots do not remove the surgeon. They move procedures from open and standard laparoscopic technique to robotic technique, and each move changes who stands at the table. The first assistant who holds retractors and the scrub tech who hands instruments do less of that on robotic cases. A table-mounted design aims at a different bottleneck than price: OR space. If it works, the hospitals that could not fit a cart-and-boom robot become buyers. That widens the base of robotic cases, and the staffing mix shifts with it, slowly, over the same 3-5 year window we use for Hugo.

Is this robot coming for your job?

Press releases speak in averages — LostJobs talks about your role. Find out which parts of your job hold up and which don't. Free.

Talk to LostJobs about my future